CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Chronic Total Occlusion Revascularization +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03988166
NCT03988166N/ACompleted

Chronic Total Occlusion Percutaneous Coronary Intervention CTO-PCI Study

Vascular Solutions LLC·interventional·Posted Jun 17, 2019·Updated Sep 28, 2022

In Brief

A clinical study evaluating Chronic Total Occlusion Revascularization and GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheter for Chronic Total Occlusion and 2 related conditions. Completed, enrolled 150 participants across 13 sites.

Detailed Summary

The objective of this study is to evaluate angiographic confirmation of placement of any guidewire beyond the CTO, in the true vessel lumen, in patients undergoing CTO percutaneous coronary intervention (PCI) in which at least one Teleflex guidewire and at least one Turnpike catheter are used.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 17, 2019
Enrollment StartMay 20, 2020
Primary CompletionFeb 22, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.0 years ago

Interventions

Chronic Total Occlusion Revascularizationprocedure

Teleflex's series of study guidewires and catheters will be used to facilitate the safe and effective crossing of de novo CTOs and placement of conventional guidewires beyond the lesion via either a true lumen or subintimal pathway.

GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheterdevice

GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheter